Kusajili – Clinical trials directory

Result of your search per sponsor: Bengt G Gustavsson, PhD, MD

Woman and Man Max 99 years
Bengt G Gustavsson, PhD, MD Update Il y a 4 ans

An Extended Feasibility Phase I/II Study of Methylenetetrahydrofolate and Pemetrexed Single Agent, Given as Neoadjuvant Treatment in Patients With Resectable Rectal Cancer The purpose of this study is to determine whether an optimal dose of [6R] 5,10-methylenetetrahydrofolate (Modufolin) in combination with pemetrexed are effective in pre-operative treatment...

Country Sweden
organs None
Specialty None

Closed trial

More information